Jia HL - Search Results

1

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients.

Zhang XF, Yang X, Jia HL, Zhu WW, Lu L, Shi W, Zhang H, Chen JH, Tao YF, Wang ZX, Yang J, Wang LX, Lu M, Zheng Y, Zhao J, Dong QZ, Qin LX. Zhang XF, et al. Among authors: jia hl. Cancer Biol Med. 2016 Dec;13(4):459-468. doi: 10.20892/j.issn.2095-3941.2016.0077. Cancer Biol Med. 2016. PMID: 28154777 Free PMC article.

2

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Ji Y, Huang LW, Jia HL, Sun HC, Wang L. Qin LX, et al. Among authors: jia hl. World J Gastroenterol. 2002 Jun;8(3):459-63. doi: 10.3748/wjg.v8.i3.459. World J Gastroenterol. 2002. PMID: 12046070 Free PMC article.

3

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW. Budhu A, et al. Among authors: jia hl. Cancer Cell. 2006 Aug;10(2):99-111. doi: 10.1016/j.ccr.2006.06.016. Cancer Cell. 2006. PMID: 16904609 Free article.

4

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW. Jia HL, et al. Clin Cancer Res. 2007 Feb 15;13(4):1133-9. doi: 10.1158/1078-0432.CCR-06-1025. Clin Cancer Res. 2007. PMID: 17317821

5

Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma.

Lei KF, Wang YF, Zhu XQ, Lu PC, Sun BS, Jia HL, Ren N, Ye QH, Sun HC, Wang L, Tang ZY, Qin LX. Lei KF, et al. Among authors: jia hl. BMC Cancer. 2007 Sep 4;7:172. doi: 10.1186/1471-2407-7-172. BMC Cancer. 2007. PMID: 17784942 Free PMC article.

6

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Budhu A, et al. Among authors: jia hl. Hepatology. 2008 Mar;47(3):897-907. doi: 10.1002/hep.22160. Hepatology. 2008. PMID: 18176954

7

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW. Yamashita T, et al. Cancer Res. 2008 Mar 1;68(5):1451-61. doi: 10.1158/0008-5472.CAN-07-6013. Cancer Res. 2008. PMID: 18316609

8

[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].

Jia HL, Xing XJ, Ye QH, Qin LX. Jia HL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):440-3. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008. PMID: 18795617 Clinical Trial. Chinese.

9

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX. Sun BS, et al. Among authors: jia hl. Hepatology. 2008 Dec;48(6):1834-42. doi: 10.1002/hep.22531. Hepatology. 2008. PMID: 18972404

10

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW. Yamashita T, et al. Gastroenterology. 2009 Mar;136(3):1012-24. doi: 10.1053/j.gastro.2008.12.004. Epub 2008 Dec 6. Gastroenterology. 2009. PMID: 19150350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters